Evidence map›Paper›PMID 42342957›Full record

ArticleInsights into imaging2026

A perioperative multi-modal fusion and deep learning-based prognostic system for upper tract urothelial carcinoma: a multi-institutional study.

Xiang Peng, Yang Li, Wei Shi, Bangxin Xiao, Xiao Xiao, Xiaofeng Yue, Qiao Xv, Qing Jiang, Weiyang He, Yingjie Xv and 1 more

Abstract read
In one paragraph

Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiang Peng *Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yang Li *Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Wei Shi *Center for Reproductive Medicine, Women and Children's Hospital of Chongqing Medical University, Chongqing Health Center for Women and Children, Chongqing, China.
Bangxin XiaoDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiao XiaoDepartment of Urology, Chongqing University Fuling Hospital, Chongqing, China.
Xiaofeng YueDepartment of Urology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qiao XvDepartment of Urology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
Qing JiangDepartment of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Weiyang HeDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yingjie XvDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 3088027375@qq.com.
Mingzhao XiaoDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. mingzhaoxiao@cqmu.edu.cn.ORCID http://orcid.org/0000-0001-6989-5971

Funding

Annual Research Projects of Chongqing Research Association for Science Popularization 2024CQKPB006Chongqing Municipal Education Commission's 14th Five-Year Key Discipline Support Project No.20240101the Graduate Education and Teaching Reform Project of the First Affiliated Hospital of Chongqing Medical University jgxm-202502the Medical Health Care Ecosystem Innovation Team of the First Affiliated Hospital of Chongqing Medical University CYYY-DSTDXM-202409
6 · The paper itself

Abstract

objectivesPrecise perioperative risk stratification for upper tract urothelial carcinoma (UTUC) is essential. We developed a multimodal prognostic model integrating perioperative clinical data, radiomics, and deep learning (DL) features from baseline CT urography to improve survival prediction and guide adjuvant management. MATERIALS AND

methodsWe retrospectively enrolled 623 patients from six institutions, divided into training, internal validation, and independent external validation sets. Four single-modal models (clinical, radiomics, 2D DL, and 2.5D DL) were developed, and an integrated combined model was constructed by fusing their prognostic scores. Performance was evaluated using the C-index, area under the curve (AUC), calibration curves, and decision curve analysis (DCA).

resultsThe combined model consistently outperformed all single-modal models across all cohorts. C-indices reached 0.758 (95% CI: 0.712-0.804), 0.725 (95% CI: 0.651-0.798), and 0.704 (95% CI: 0.631-0.777) in the training, internal validation, and external validation sets, respectively, numerically surpassing the best single-modal models. Notably, our 2.5D DL model (C-index: 0.705) demonstrated a consistent incremental improvement over the 2D DL model (C-index: 0.681) in capturing prognostic information. In external validation, the combined model achieved a 3-year AUC of 0.766. DCA indicated the comprehensive model exhibited excellent calibration and provided the highest net benefits.

conclusionThis multimodal system, featuring a robust 2.5D DL strategy, improves overall survival prediction in UTUC. It offers a valuable tool for accurate perioperative risk stratification immediately after radical nephroureterectomy, demonstrating particularly reliable value for 3-year intermediate-term clinical decision-making. CRITICAL RELEVANCE STATEMENT: This multimodal system advances clinical radiology by fusing perioperative clinical data, radiomics, and DL features from CTU images, enhancing risk stratification accuracy to guide postoperative adjuvant management for UTUC. KEY POINTS: Current prognostic models for UTUC lack accuracy, creating an unmet clinical need for precise perioperative risk stratification to guide adjuvant management. A multimodal prognostic model fusing clinical, radiomic, and DL features from baseline CT urography consistently outperformed single-modality models in predicting overall survival.

Indexed as

Computed tomographyDeep learningPrognosisRadiomicsUrothelial carcinoma

Identifiers

PMID42342957
PMCPMC13294415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.